Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice

November 18, 2026 - 09:00
 0  0
Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice

Regular alcohol use may undermine a widely used form of cancer immunotherapy by dampening some T cells while boosting others, according to a new study in mouse models and a retrospective patient cohort. The findings point to a molecular route by which drinking weakens anti-tumor immunity, and to ways it might be countered.

The work, from researchers at the University of North Carolina at Chapel Hill, was published in Science Signaling in a paper titled “Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting antitumor immunity.” Immune checkpoint inhibition has improved outcomes for some patients with advanced cancers, but relatively few have a complete response. Alcohol use is common and impairs adaptive immunity. Recent studies suggest that as many as 76.4% of patients with cancer still drink, and medical societies have called for more research on how alcohol affects treatment outcomes.

To probe the link, the team gave mouse models of lung and bladder cancer a moderate-to-heavy amount of ethanol while treating them with anti-PD-1 antibodies. In both models, alcohol reduced the efficacy of the immunotherapy by roughly 50% and increased tumor recurrence.

In mice with MB49 bladder tumors, ethanol reduced the number of tumor-infiltrating T cells and shifted tumor-associated CD4+ T cells toward a T helper 17 profile over a T helper 1 profile. It also reduced tissue-resident memory T cells while increasing the proportion of T cells expressing TIGIT, an alternative immune checkpoint receptor, and induced SREBP-mediated lipid signaling in tumor-associated T cells, according to the paper.

Targeting those changes helped. Blocking TIGIT with antibodies restored the efficacy of anti-PD-1 treatment in the animals, while inhibiting SREBP signaling with betulin improved it to a lesser extent.

The researchers then retrospectively analyzed a cohort of patients with skin, lung, bladder, or head and neck cancer treated with immune checkpoint inhibitors. Patients who self-reported eight or more drinks a week had poorer survival after starting treatment. In patients with lung cancer, regular alcohol use was associated with a reduced survival benefit from immune checkpoint inhibition. The effects were less definitive in the other cancers because alcohol use reporting was too limited.

“This work is an initial resource toward establishing the risk of regular alcohol use on the efficacy of [immune checkpoint inhibition] and identifying the mechanisms that might be targeted for intervention,” Gilley et al. wrote. As next steps, the authors say that incorporating patients’ alcohol use into cancer databases will help define its effect on outcomes of various therapies, such as chimeric antigen receptor T cell therapy (CAR T cell therapy), chemotherapy, and radiation, across multiple cancers.

The post Alcohol Suppresses Some T Cells, Boosts Others, Blunting Anti-PD-1 Response in Mice appeared first on GEN - Genetic Engineering and Biotechnology News.

Apa Reaksi Anda?

Suka Suka 0
Kurang Suka Kurang Suka 0
Setuju Setuju 0
Tidak Setuju Tidak Setuju 0
Bagus  Bagus 0
Berguna Berguna 0
Hebat Hebat 0
Edusehat Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. || An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.